Both in Pharmaceuticals
Emergent Biosolutions vs Turn Therapeutics
Over the past year EBS returned −36.0% and TTRX returned +102.4%; their daily moves had a correlation of 0.12.
EBS −36.0% TTRX +102.4%Growth of $1, one year, split-adjusted
| Metric | EBS | TTRX |
|---|---|---|
| Price | $6.23 | $10.28 |
| Market cap | $319.4M | $312.2M |
| Today | 0.00% | +0.98% |
| 1 month | −8.0% | −22.5% |
| 6 months | −22.4% | +190.0% |
| Year to date | −49.6% | +160.9% |
| 1 year | −33.9% | +145.9% |
| Revenue growth (YoY) | +66.3% | — |
| Gross margin | 58.6% | — |
| Net margin | −76.9% | — |
| P/E (TTM) | — | — |
| Price / sales | 0.4× | — |
| Net cash | -$442.1M | $4.2M |
| Dividend yield | — | — |
| Volatility (60d) | 96.7% | 91.8% |
| Short % of float | 18.5% | 1.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).